Incannex Healthcare’s $93.3 Million Acquisition of APIRx Pharmaceuticals

Thomson Geer advised Incannex Healthcare on the acquisition of APIRx Pharmaceuticals.Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), a clinical-stage pharmaceutical company developing unique medicinal cannabis pharmaceutical…

This content is for Standard 1 Year members only.
Login Join Now
Sonia Carcano

Author: Sonia Carcano

This content is for Standard 1 Year members only.
Login Join Now